ES516712A0 - Procedimiento para la obtencion de esteroides dihalogenados. - Google Patents

Procedimiento para la obtencion de esteroides dihalogenados.

Info

Publication number
ES516712A0
ES516712A0 ES516712A ES516712A ES516712A0 ES 516712 A0 ES516712 A0 ES 516712A0 ES 516712 A ES516712 A ES 516712A ES 516712 A ES516712 A ES 516712A ES 516712 A0 ES516712 A0 ES 516712A0
Authority
ES
Spain
Prior art keywords
dihalogenated
steroids
procedure
obtaining
obtaining dihalogenated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES516712A
Other languages
English (en)
Other versions
ES8405033A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG filed Critical Ciba Geigy AG
Publication of ES516712A0 publication Critical patent/ES516712A0/es
Publication of ES8405033A1 publication Critical patent/ES8405033A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J7/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/008Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21
    • C07J7/0085Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21 by an halogen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0061Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
    • C07J5/0069Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
    • C07J5/0076Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group by an alkyl group

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ES516712A 1981-10-23 1982-10-21 Procedimiento para la obtencion de esteroides dihalogenados. Expired ES8405033A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH679081 1981-10-23

Publications (2)

Publication Number Publication Date
ES516712A0 true ES516712A0 (es) 1984-05-16
ES8405033A1 ES8405033A1 (es) 1984-05-16

Family

ID=4315071

Family Applications (1)

Application Number Title Priority Date Filing Date
ES516712A Expired ES8405033A1 (es) 1981-10-23 1982-10-21 Procedimiento para la obtencion de esteroides dihalogenados.

Country Status (12)

Country Link
EP (1) EP0078235A3 (es)
JP (1) JPS5879998A (es)
AU (1) AU8970182A (es)
DK (1) DK469482A (es)
ES (1) ES8405033A1 (es)
FI (1) FI823586L (es)
GB (1) GB2108504A (es)
GR (1) GR76767B (es)
IL (1) IL67048A0 (es)
NO (1) NO823515L (es)
PT (1) PT75718B (es)
ZA (1) ZA827737B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY110603A (en) * 1993-05-27 1998-08-29 Novartis Ag Tetrahydropyran derivatives
US7184535B1 (en) 1999-02-26 2007-02-27 Bellsouth Intellectual Property Corporation Methods and systems for releasing a voice mail system from a communication and further processing the communication

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB898292A (en) * 1959-03-18 1962-06-06 Upjohn Co Improvements in or relating to steroids and the manufacture thereof
US3629242A (en) * 1969-03-03 1971-12-21 Syntex Corp 6-gem-difluoro steroids
US3832366A (en) * 1973-07-30 1974-08-27 Squibb & Sons Inc Process for preparing 21-chloro-17-acyloxy-20-ketosteroids
DE2655570A1 (de) * 1975-12-12 1977-06-16 Ciba Geigy Ag Neue polyhalogensteroide und verfahren zu ihrer herstellung
US4361558A (en) * 1980-04-29 1982-11-30 Ciba-Geigy Corporation Halogenated steroids

Also Published As

Publication number Publication date
PT75718B (de) 1985-12-03
DK469482A (da) 1983-04-24
FI823586A0 (fi) 1982-10-20
PT75718A (de) 1982-11-01
ZA827737B (en) 1983-08-31
JPS5879998A (ja) 1983-05-13
EP0078235A2 (de) 1983-05-04
FI823586L (fi) 1983-04-24
AU8970182A (en) 1983-05-12
NO823515L (no) 1983-04-25
GB2108504A (en) 1983-05-18
IL67048A0 (en) 1983-02-23
GR76767B (es) 1984-09-03
ES8405033A1 (es) 1984-05-16
EP0078235A3 (de) 1983-06-29

Similar Documents

Publication Publication Date Title
ES510255A0 (es) Procedimiento para la obtencion de poliisocianatos.
ES516368A0 (es) Procedimiento para la obtencion de fenoxifenil-azol-metilcetonas y-carbinoles.
ES515084A0 (es) Procedimiento para la obtencion de 2-arilimidazopiridinas.
ES520273A0 (es) Procedimiento para la obtencion de trimetilolpropano.
ES524346A0 (es) Procedimiento para la obtencion de poliaminas primarias.
ES511387A0 (es) Procedimiento para la obtencion de poliesteres.
ES516717A0 (es) Procedimiento para la obtencion de derivados de trifluormetil-fenoxifenil-silicio.
ES516841A0 (es) Procedimiento para la obtencion de benzofuranonas
ES514300A0 (es) Procedimiento para la obtencion de poliisocianatos.
ES515445A0 (es) Procedimiento para la obtencion de amino-organoaminosilosanos.
ES516842A0 (es) Procedimiento para la obtencion de benzofuranonas.
ES508803A0 (es) Procedimiento para la obtencion de derivados de sisomicina.
ES507523A0 (es) Procedimiento para la obtencion de disulfuros de xantogeno.
ES532240A0 (es) Procedimiento para la obtencion de benzoil-ureas.
ES518617A0 (es) Procedimiento para la obtencion de p-tercioctil-fenol.
ES522323A0 (es) Procedimiento para la obtencion de 2-halogenopropionatos sustituidos.
ES510596A0 (es) Procedimiento para la obtencion de 3-alquen-i-il-2,3-dimetil-ciclopropancarboxilatos de 4-fluor-3-fenoxi-bencilo.
ES511911A0 (es) Procedimiento para la obtencion de derivzados de aminociclitol.
ES522474A0 (es) Procedimiento para la obtencion de halogenopropargilformamidas.
ES516712A0 (es) Procedimiento para la obtencion de esteroides dihalogenados.
ES519809A0 (es) Procedimiento para la obtencion de oxazolidin-2-onas.
ES510955A0 (es) Procedimiento para la obtencion de metilomelaminas monomeras
ES512786A0 (es) Procedimiento para la obtencion de o-alquiluretanos n-monosustituidos.
ES510752A0 (es) Procedimiento para la obtencion de esteres de fenoxipiridilmetilo.
ES511969A0 (es) Procedimiento para la obtencion de 2-aminoetanoles sustituidos.